Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others
Huili Li(Penn State Milton S. Hershey Medical Center), Andrés Matoso(Johns Hopkins University)
Cited by 39
Related Papers
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
|Scientific Reports|2020|59
A Comparative Analysis of Edwardsiella tarda-Induced Transcriptome Profiles in RAW264.7 Cells Reveals New Insights into the Strategy of Bacterial Immune Evasion
|International Journal of Molecular Sciences|2019|35